Refine Your Results

Click below to filter your search results

"Last Month"Undo
"Gynecologic Cancers"Undo
Return to List
Results 1–1 of 1
Title Date
1.

Tamoxifen and Uterine Cancer

Number 601

(Replaces Committee Opinion Number 336, June 2006)

ABSTRACT: Tamoxifen, a nonsteroidal antiestrogen agent, is widely used as adjunctive therapy for women with breast cancer, and it has been approved by the U.S. Food and Drug Administration for adjuva...

June 2014

PDF Format